Facial photoaging
Conditions
Interventions
Test side:Aesthetic surgery
Product usage: The test subjects used RiROquan Revitalizing Repair cream from D0 to D84, and added Riroquan Revitalizing Repair Essence from D15 to D84
Control side:Aesthetic surgery
Product use: Subjects used control cream from D0 to D84 on the control side face
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
24 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1)Chinese women or men aged 25-45 in good health (including 45 years old); 2) The subject's unilateral crow's feet and decree lines conform to L 'Oreal Skin Aging Map 2= grade =5); 3) The subject agrees to undergo photon rejuvenation or picosecond laser (rejuvenation mode) treatment; 4) The subject agrees not to expose himself to the sun and to take protective measures to avoid excessive exposure to the sun (wear a hat and use a parasol when going out); 5) The subject agrees not to use any new cosmetic or personal care products during the study other than the specified test products. 6) Have good compliance; 7) Good communication and understanding skills; 8) Willing to answer the questionnaire regularly and on time; 9) Volunteer to participate in this clinical study, have read the informed consent and signed the consent;
Exclusion criteria
Exclusion criteria: 1)Breastfeeding or pregnant women, or subjects with recent plans to become pregnant or breastfeed; 2) The subject is using or has been systematically or topically using corticosteroids, antihistamines, vasoconstrictors, antibiotics, anti-inflammatory drugs, or other drugs that may affect the trial within 2 weeks prior to the start of the trial; 3) The subject is known to be allergic to cosmetics, sunscreen or personal care products; 4) The subject has a history of adverse reactions to products of the same type as the test product; 5) Subjects with a history of acute or chronic skin disease, drug allergy and/or a history that interferes with the use of the test product and/or may affect the study results; 6) Participants have participated in clinical or cosmetic studies within 3 months from the start of the study; 7) The subject has a medical condition or situation that, in the investigator's opinion, may place the subject at significant risk and may interfere with the study results; 8) Subjects with any concomitant health conditions that may increase the risk associated with participation in the trial or that may interfere with the trial results (such as peripheral neuropathy, kidney failure, uremia, history of uncontrolled thyroid disease, uncontrolled diabetes or diabetic neuropathy, etc.); 9) Have a history of mental and mental illness; 10) People with active herpes simplex.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin damage repair effect;Anti aging effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin tone improvement degree;Security evaluation index; | — |
Countries
China
Contacts
Public ContactZou Ying
Shanghai Skin Disease Hospital
Outcome results
None listed